This article breaks down Chemed (NYSE: CHE), which owns hospice provider VITAS and plumbing service Roto-Rooter. The key idea: Chemed's management focuses solely on growing per-share free cash flow, so they have aggressively bought back shares (shares down 40% since 2004), driving 21% annual EPS growth. The author is optimistic, citing aging demographics for VITAS and Roto-Rooter's strong brand in emergency plumbing. Chemed is the only holding mentioned; it has a net cash balance sheet and a long track record of price appreciation.
Chemed (NYSE: CHE) has achieved exceptional capital allocation and growth by integrating two seemingly unrelated businesses: hospice care (VITAS) and plumbing services (Roto-Rooter). Since 2003, the company's EPS compound annual growth rate has reached 21%, with a current market capitalization of ap
Chadd Garcia (portfolio manager of Ave Maria Focused Fund) analyzes Chemed—a company that combines hospice care (VITAS) with plumbing services (Roto-Rooter). The core judgment is: Chemed's mission is to grow free cash flow per share, not to manage specific businesses; this philosophy has driven a 21% compound annual growth rate in EPS since 2003, resulting in an $8.5 billion market capitalization and a net cash balance sheet.
Chadd Garcia argues that Chemed's competitive advantage lies not in its business itself, but in its capital allocation culture, which is singularly focused on "growing per-share free cash flow." The architect of this culture is CEO Lawrence Mendelson, who stated: "We are not in the aerospace or defense industry; we are in the business of growing per-share free cash flow." Management has repeatedly told guests that they are "agnostic" about the business portfolio — if someone offers the right price, any subsidiary could be sold; if a better business appears, they could enter it.
The historical track record supports this view. Chemed originated from a spin-off of W.R. Grace in the 1970s, initially owning specialty chemicals, Omnicare (pharmacy services), and Roto-Rooter. It acquired Roto-Rooter in the 1980s, then spun off Omnicare; in the 1990s, it sold the chemicals business at a high price, generating substantial cash, and used that to take a stake in VITAS (fully acquired in 2004). From 2004 to the present, the two subsidiaries have made almost no large-scale acquisitions, relying primarily on organic growth and sporadic bolt-on deals (Roto-Rooter buying franchise rights, VITAS completing an $85 million acquisition in 2024).
Capital allocation data chain: Since 2004, the company has generated approximately $3.7 billion in free cash flow (after deducting $600-800 million in capex). Of this, $700 million was used for M&A, $300 million for dividends (very small and steadily growing, aimed at satisfying certain institutional investor requirements), and $2.5 billion for share buybacks. Share count has fallen from 25 million shares in 2004 to 15 million shares currently. As a result, EPS has compounded at 21% annually from 2003 to the present, and the stock price has appreciated at a similar pace.
Implication: The guest believes that as long as management maintains this philosophy, capital allocation will continue to be the core driver of value creation. Falsification condition: If management deviates from the "grow per-share free cash flow" goal and instead pursues large-scale, low-return M&A or stops buybacks, the thesis would be invalidated.
Chadd Garcia believes that Roto-Rooter's core advantage is its brand mindshare in the "emergency plumbing service" category, making it the preferred choice in 70–75% of immediate service calls. The business was founded by Sam Blanc in the 1930s and expanded through a licensed franchise model. Currently, the company operates under three models: company-owned branches (large cities, highest control), independent contractors (paying 28% royalty, receiving headquarters back-office and marketing support), and franchisees (paying a small fixed fee, receiving almost no support). The company continuously acquires franchises, converting them into company-owned branches or contractor models.
Competitive landscape: The plumbing market is highly fragmented. Roto-Rooter holds a 2–3% share in the overall plumbing market and a 15% share in the drain cleaning market. After 2021, private equity entered the space (e.g., Alpine Investors' Apex, Ben Franklin), poaching 20% of Roto-Rooter's general managers, along with the layer of managers below them. However, "within a year and a half, half of the GMs who left returned to Roto-Rooter", which the guest believes proves the appeal of being an "owner" rather than a "tenant". Private equity firms are trying to scale by integrating HVAC and other businesses, but Roto-Rooter itself attempted HVAC in the 1990s and failed, so the guest is skeptical about competitors' success.
Recent challenges: During COVID, Roto-Rooter benefited greatly from work-from-home (increased home usage led to equipment failures), but subsequently experienced negative growth: negative year-over-year from Q1 2023, with leads dropping 7–8%. Causes include inflation prompting some DIY alternatives and intensified SEO competition from private equity. However, company-owned branches performed strongly, indicating the company is improving conversion rates. EBITDA margin is around 25%, stable over the long term.
Deduction: The guest believes Roto-Rooter's brand still retains a moat in emergency services, and its branch model is more stable than that of private equity. Falsification conditions: If private equity continues to poach on a large scale and SEO competition leads to a long-term decline in brand search volume, or if a macroeconomic recession causes demand for non-emergency services to shrink, the moat could be weakened.
Chadd Garcia believes that VITAS is at the starting point of a major demographic trend, and its scale advantage allows it to withstand short-term fluctuations in government reimbursement. Hospice care services have 93% of their bills paid by Medicare, and the government bears approximately 30% of Medicare spending for end-stage patients each year, most of which goes toward ineffective curative treatments. VITAS provides home-based palliative care, reducing unnecessary emergency room visits and hospitalizations for patients, thereby saving substantial funds for Medicare. Therefore, the government has an incentive to support the industry.
Key Data: Annual U.S. deaths have increased from 2.5 million pre-COVID to approximately 3 million currently, and are expected to rise to 4.5 million by the 2040s and remain elevated for the long term. VITAS currently holds approximately 12% of the hospice care market, with 2024 revenue of about $1.6 billion and an EBITDA margin of 15-22%. Its growth is primarily organic (greenfield capacity expansion), with historical compound revenue growth of 6% and earnings growth of 12%.
Mechanism Breakdown: VITAS chooses to operate in densely populated states with strict regulations to maximize employee utilization. For example, Los Angeles County, California has 1,900 hospice care operators, while Florida has only 50. VITAS primarily deploys in heavily regulated states, allowing its margins to reach 2-3 times the bottom 50% of the industry (6-9%). Additionally, VITAS manages Medicare's two caps through a diversified patient source mix (hospitals, nursing homes, homes): the high-cost care cap (not exceeding 20% of total billing) and the total cost cap (currently $34,560 per person). Its mix structure makes it difficult to breach either cap.
Response During COVID-19: From 2020 to 2022, government reimbursement increased slowly, but VITAS invested $37 million in nurse retention bonuses and an additional $3 million in recruitment, allowing it to quickly capture market share after healthcare facilities reopened. Starting from Q4 2022, revenue grew by double digits year-over-year consecutively.
Administration and Sales: VITAS uses a field sales team to visit hospitals and nursing homes to obtain patient referrals. Falsification Conditions: If the government significantly cuts hospice care reimbursement rates (although the guest believes the long-term probability is low, it could occur in the short term due to fiscal pressure), or if industry consolidation leads to independent agencies being replaced by affiliated healthcare institutions, VITAS's independent model may face challenges.
| Target | Analyst's View | Key Data |
|---|---|---|
| Chemed (NYSE: CHE) | Bullish (hold for observation) | Market cap $8.5B, net cash; 2003–2024 EPS CAGR 21%; repurchased $2.5B since 2004, share count reduced from 25M to 15M; 2024 revenue approx. $2.5B, EBITDA $500–600M |
Note: VITAS and Roto-Rooter are wholly-owned subsidiaries of Chemed, not separately listed companies, so they are not listed individually; their business details are covered in the topic sections above.
1. “Chemed’s mission is to grow free cash flow per share, not to manage a specific business” (Chadd Garcia) — CEO Lawrence Mendelson stated that the company is not in aerospace or defense, but in growing free cash flow per share. Management walks the talk, having repurchased $2.5 billion in stock since 2004, reducing share count by 40%.
2. “Roto-Rooter’s emergency services (70-75% of business) provide a brand moat, and customers are not price-sensitive” (Chadd Garcia) — Consumers think of Roto-Rooter first in plumbing emergencies, and its same-day service capability gives it a 2-3% share in a fragmented market (15% in drain cleaning).
3. “VITAS’s high margins (15-22%) come from choosing to operate in densely populated, heavily regulated states, while the bottom 50% of the industry has margins of only 6-9%” (Chadd Garcia) — Scale effects allow VITAS to better utilize staff, and strict regulation reduces local competition.
4. “VITAS is riding a major demographic trend: deaths rising from 2.5 million pre-COVID to 4.5 million in the 2040s” (Chadd Garcia) — Demand for hospice care will surge, and with Medicare covering 96% of costs, the government has an incentive to maintain a favorable reimbursement environment.
5. “Private equity poached 20% of Roto-Rooter’s general managers, but half returned within 18 months, proving that ‘owners’ are better than ‘tenants’” (Chadd Garcia) — Roto-Rooter’s long operating experience and brand attracted returning employees, while private equity failed to build a lasting advantage.
6. “VITAS manages Medicare caps (20% cap on high-cost care, total cap of $34,560) through a diversified patient source mix” (Chadd Garcia) — Hospital-sourced patients have short stays and high costs, while nursing home-sourced patients have long stays and low costs. This mix management helps VITAS avoid breaching the caps.
7. “If industry consolidation shifts toward affiliated healthcare providers (e.g., hospitals, nursing homes) dominating, the independent VITAS could be sold or used to acquire other healthcare businesses” (Chadd Garcia) — This is a potential scenario for a Chemed spin-off, but only if the competitive landscape undergoes a fundamental change.
8. “Chemed’s capital allocation discipline: net cash, minimal dividends, primarily buybacks — this structure makes it a natural capital allocator for ‘bargain hunting’” (Chadd Garcia) — The business itself generates abundant cash and requires little reinvestment; management can create sustained value simply by buying back shares aggressively when the market undervalues them.